Wondering about the most recent progress in Myasthenia Gravis treatments research and clinical trials?
Wondering about the most recent progress in myasthenia gravis treatments research and clinical trials?
Join a “What’s New in MG Research” webinar to learn about the latest research results, key clinical trial phases, and current outcomes from top research trials taking place right now.
FOR HEALTHCARE PROVIDERS
Live CME: Harnessing Approved and Emerging FcRn Blockers Across Subtypes in Antibody-Positive Generalized Myasthenia Gravis
Tuesday, September 30
11:00 AM ET / 8:00 AM PT
As part of our mission to empower patients and pursue a cure for MG, MGFA is proud to offer this free CME-accredited educational session on emerging FcRn blockers in antibody-positive generalized myasthenia gravis (gMG). Expert neurologists Dr. Gil Wolfe and Dr. Tuan Vu will provide real-world cases and insights to help providers navigate diagnostic testing, treatment selection, and emerging pharmacology in gMG.
Designed for neurologists and other HCPs, the program delivers real-world clinical guidance to help improve patient care today while driving awareness of new therapeutic possibilities on the horizon.
CME: 1.0 AMA PRA Category 1 Credits™
Presented in partnership with NORD and Medlive
Save Your SpotPresenting Partners
